Page 2304

actions if performed within the normal course of treatment or otherwise beginning no later than one year after birth or the event that caused the need for the corrective action:

(A) repair of an injury;

(B) improvement of the functioning of a malformed body member;

(C) correction of a visible disfigurement that would materially affect the recipient’s acceptance in society;

(5) a nonmedical charge imposed by a recipient’s friend or relative;

(6) for a person who is in the custody of federal, state, or local law enforcement, including a juvenile in a detention or correctional facility, except as an inpatient in a medical institution;

(7) for an experimental or investigational service, except for covered routine patient costs associated with clinical trials specified in 42 U.S.C. 1396d(gg)(1), adopted by reference in 7 AAC 160.900; for the purposes of this paragraph, an experimental or investigational service for which the department will not pay includes one

(A) that is in a phase I or II clinical trial as defined in the United States Department of Health and Human Services, National Institutes of Health, Glossary of Terms for Human Subjects Protection and Inclusion Issues, adopted by reference in 7 AAC 160.900;

(B) for which inadequate available clinical or preclinical data exists to provide a reasonable expectation that the proposed service is at least as safe and effective as one not under experiment or investigation;

(C) for which an expert has issued an opinion that additional information is needed to assess the safety or efficacy of the proposed service;

(D) for which final approval from the appropriate governmental body has not been granted for the specific indications for which the use of the service is being proposed; however, if a drug has received final approval from the United States Food and Drug Administration (FDA) for any indication, final approval is not required for the specific indication for which use is being proposed if